登录 注册 会员服务 联系我们

Novel chromobox 2 inhibitory peptide decreases tumor progression

  • Published:2023-05-04 Issue:4-5 Volume:27 Page:361-371
  • ISSN:1472-8222
  • Container-title:Expert Opinion on Therapeutic Targets
  • language:en
  • Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Brubaker Lindsay W.1ORCID,Backos Donald S.2ORCID,Nguyen Vu T.2,Reigan Philip2,Yamamoto Tomomi M3,Woodruff Elizabeth R.3,Iwanaga Ritsuko3,Wempe Michael F.2,Kumar Vijay2,Persenaire Christianne1,Watson Zachary L.3ORCID,Bitler Benjamin G.34ORCID

Affiliation:

1. Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA

2. Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado - Anschutz Medical Campus, Aurora, CO, USA

3. Department of Obstetrics & Gynecology, Division of Reproductive Sciences, The University of Colorado Anschutz Medical Campus, Aurora, CO, USA

4. University of Colorado Comprehensive Cancer Center, Aurora, CO, USA

Funder

American Cancer Society

University of Colorado

OB-GYN Academic Enrichment Fund

Gynecologic Oncology Academic Enrichment Fund

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3